Small cell neuroendocrine carcinomas of the uterine cervix: case report

Purpose: Small cell neuroendocrine carcinoma (SCNEC) in the cervix is a rare entity of cervical carcinoma associated with invasiveness and poor prognosis. There is limited knowledge of etiology of SCNEC. The diagnosis depends on pathological examination. Various treatment regimes are suggested. Case Report: In this article, the authors present a case of SCNEC. A 33-year-old woman was admitted with complaints of contact vaginal bleeding for one week. Pathological examination showed that synaptophysin (Syn) and CD56 were positive in tumor cells and the case was single cell type SCNEC. For this case, the authors selected TP regime after surgery and achieved better outcome. Conclusion: Combination of surgery, radiotherapy, and chemotherapy is recommended to treat the patients.

Pathological characteristic; SCNEC; TP regime.

[1] Ganesan R., Hirschowitz L., Dawson P., Askew S., Pearmain P., Jones P.W., et al.: “Neuroendocrine carcinoma of the cervix: review of a series of cases and correlation with outcome”. Int. J. Surg. Pathol., 2016, 24, 490.

[2] Albores-Saavedra J., Gersell D., Gilks C.B., Henson D.E., Lindberg G., Santiago H., et al.: “Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute”. Arch. Pathol. Lab. Med., 1997, 121, 34.

[3] Zivanovic O., Leitao M.M. Jr., Park K.J., Zhao H., Diaz J.P., Konner J., et al.: “Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinumbased combination chemotherapy”. Gynecol. Oncol., 2009, 112, 590.

[4] Ishida G.M., Kato N., Hayasaka T., Saito M., Kobayashi H., Katayama Y., et al.: “Small cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical, and molecular genetic study”. Int. J. Gynecol. Pathol., 2004, 23, 366.

[5] Wolber R.A., Clement P.B.: “In situ DNA hybridization of cervical small cell carcinoma and adenocarcinoma using biotin-labeled human Papillomavirus probes”. Mod. Pathol., 1991, 4, 96.

[6] Viswanathan A.N., Deavers M.T., Jhingran A., Ramirez P.T., Levenback C., Eifel P.J.: “Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence”. Gynecol. Oncol., 2004, 93, 27.

[7] Crowder S., Tuller E.: “Small cell carcinoma of the female genital tract”. Semin. Oncol., 2007, 34, 57.

[8] Bermudez A., Vighi S., Garcia A., Sardi J.: “Neuroendocrine cervical carcinoma: a diagnostic and therapeutic challenge”. Gynecol. Oncol., 2001, 82, 32.

[9] Trinh X.B., Bogers J.J., Van Marck E.A., Tjalma W.A.: “Treatment policy of neuroendocrine small cell cancer of the cervix”. Eur. J. Gynaecol. Oncol., 2004, 25, 40.

[10] Van Nagell J.R. Jr., Donaldson E.S., Wood E.G., Maruyama Y., Utley J.: “Small cell cancer of the uterine cervix”. Cancer, 1977, 40, 2243.

[11] Alphandery C., Dagrada G., Frattini M., Perrone F., Pilotti S.: “Neu roendocrine small cell carcinoma of the cervix associated with endocervical adenocarcinoma: a case report”. Acta. Cytol., 2007, 51, 589.

[12] Chan J.K., Loizzi V., Burger R.A., Rutgers J., Monk B.J.: “Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis”. Cancer, 2003, 97, 568.

[13] Kajiwara H., Hirabayashi K., Miyazawa M., Nakamura N., Hirasawa T., Muramatsu T., et al.: “Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine carcinoma of uterine cervix”. Arch. Gynecol. Obstet., 2009, 279, 521.

[14] Korcum A.F., Aksu G., Ozdogan M., Erdogan G., Taskin O.: “StageI small cell carcinoma of the endometrium: survival and management options”. Acta Obstet. Gynecol. Scand., 2008, 87, 122.

[15] Hoskins P.J., Swenerton K.D., Pike J.A., Lim P., Aquino-Parsons C., Wong F., et al.: “Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy”. J. Clin. Oncol., 2003, 21, 3495.